Renaissance Technologies

The Affect Of Cymbalta’s Patent Expiration

Cymbalta is widely prescribed as an antidepressant. It is also used for chronic pain from fybromyalgia, diabetic neuropathy and musculoskeletal pain. Cymbalta’s patent is held by Eli Lilly which is one of the top five holdings of Renaissance Technologies.

Jim Simons founded Renaissance Technologies in 1982. He currently serves as a non-executive Chairman. Renaissance Technologies has come to be considered as one of the largest and most successful American hedge funds. It has had annual returns of 30% or more in each of the previous two years. Renaissance Technologies’ success is due to computer-based models that identify opportunities created by … Read the rest

Tags: , , , , , , ,

Posted in Health | Comments Off on The Affect Of Cymbalta’s Patent Expiration